Table 2.

Characteristics of aGVHD before MSC treatment.

Characteristics of aGVHD	aGVHD (n = 14)
Severity of aGVHD, n (%)
Grade II	4 (28.6)
Grade III	6 (42.8)
Grade IV	4 (28.6)
Site of aGVHD, n (%)
Skin	9 (64.3)
GI	13 (92.9)
Liver	1 (7.1)
Number of sites, n (%)
1	6 (42.9)
2	7 (50.0)
3	1 (7.1)
Total aGVHD treatments before MSC, median (range)	4 (3–5)
Second-line aGVHD treatments before MSC, n (%)
1	5 (35.7)
2	6 (42.9)
⩾3	3 (21.4)

aGVHD, acute graft-versus-host disease; GI, gastrointestinal tract; MSC, mesenchymal stromal cell.